Ezetimibe and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, also take Aspirin, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Hyperventilation when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,841 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Hyperventilation?

Hyperventilation is found to be associated with 782 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Mar, 12, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 11 people (0.04%) have Hyperventilation.

Among these 11 people:

What is the gender of people who have Hyperventilation when taking Ezetimibe? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Hyperventilation when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

Aspirin: 5 people, 45.45%
Simvastatin: 4 people, 36.36%
Mirtazapine: 3 people, 27.27%
Atenolol: 3 people, 27.27%
Citalopram Hydrobromide: 3 people, 27.27%
Pantoprazole: 3 people, 27.27%
Pitavastatin Calcium: 2 people, 18.18%
Nexium: 2 people, 18.18%
Nifedipine: 2 people, 18.18%
Zolpidem Tartrate: 2 people, 18.18%

What are other side effects people have besides Hyperventilation? *

Dyskinesia (abnormality or impairment of voluntary movement): 5 people, 45.45%
Constipation: 3 people, 27.27%
Sleep Apnea Syndrome: 3 people, 27.27%
Dyspnea (difficult or laboured breathing): 3 people, 27.27%
Transferrin Saturation Decreased: 3 people, 27.27%
General Physical Health Deterioration (weak health status): 3 people, 27.27%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 27.27%
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 3 people, 27.27%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 18.18%
On And Off Phenomenon: 2 people, 18.18%

What are the existing conditions these people have? *

Parkinson's Disease: 2 people, 18.18%
Depression: 2 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 9.09%
Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 1 person, 9.09%
Dementia (madness): 1 person, 9.09%
Bowel Movement Irregularity: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,841 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (782 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,444 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.